The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Genome-wide DNA methylation profiling of gastrointestinal neuroendocrine tumors to identify hypermethylation of mTOR, Wnt, and Notch pathways in GI NET pathogenesis.
Anna Karpathakis
No relevant relationships to disclose
Harpreet Dibra
No relevant relationships to disclose
Tiffany Morris
No relevant relationships to disclose
Dahmane Oukrife
No relevant relationships to disclose
Christodoulos P Pipinikas
No relevant relationships to disclose
Kerra Pearce
No relevant relationships to disclose
Joshua Francis
No relevant relationships to disclose
Marinos Pericleous
No relevant relationships to disclose
Dalvinder Mandair
No relevant relationships to disclose
Andrew Feber
No relevant relationships to disclose
Christos Toumpanakis
No relevant relationships to disclose
Tu Vinh Luong
No relevant relationships to disclose
Matthew Meyerson
Consultant or Advisory Role - Foundation Medicine; Novartis
Stock Ownership - Foundation Medicine
Martyn E Caplin
No relevant relationships to disclose
Stephan Beck
No relevant relationships to disclose
Christina Thirlwell
No relevant relationships to disclose